Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 1Phase 1 1

Status

Unknown 7Recruiting 2Not yet recruiting 2Completed 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 50OTHER_GOV 7INDUSTRY 3UNKNOWN 2NIH 1NETWORK 1

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 2Tumor-Agnostic 1Gynecologic 1

Conditions

Nasopharyngeal Carcinoma 2Recurrence 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Cholangiocarcinoma 1

Interventions

apatinib 25Cisplatin 19Capecitabine 17Irinotecan 16Cyclophosphamide 15fludarabine 13Radiotherapy 12Oxaliplatin 12camrelizumab 11Paclitaxel 11Drug Therapy 11S 1 (combination) 10Carboplatin 10Fluorouracil 9Docetaxel 9Blood Specimen Collection 9Bevacizumab 9Radiation 7Pemetrexed 7Nivolumab 7Gemcitabine 7Erlotinib Hydrochloride 7tislelizumab 6Surgical Procedures, Operative 6Neoadjuvant Therapy 6Albumin-Bound Paclitaxel 6toripalimab 5XELOX 5Tamoxifen 5Propranolol 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Unknown × OTHER_GOV × Radiation × Clear all
NCT05088889 2023-11-28

Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer

Sheba Medical Center

Phase 1 Unknown
10 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02773485 2022-10-21

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

Tata Memorial Hospital

Phase 3 Unknown
155 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT05007145 2021-12-21

REVO

Fujian Cancer Hospital

Phase 2 Unknown
92 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04220528 2020-01-07

Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

Fujian Cancer Hospital

Phase 2 Unknown
129 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT03412526 2019-04-04

Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian

Sheba Medical Center

Phase 2 Unknown
15 enrolled
Gynecologic

Ovarian Neoplasms

NCT03666221 2018-09-11

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma

Fujian Cancer Hospital

Phase 2 Unknown
67 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Recurrence

NCT00781209 2008-10-28

The Role of Posterior Fossa Irradiation (PFI) Plus Stereotactic Radiosurgery (SRS) for Cerebellar Metastases

Tel-Aviv Sourasky Medical Center

Phase 2 Unknown
30 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡